Basophil CD203c Levels Are Increased at Baseline and Can Be Used to Monitor Omalizumab Treatment in Subjects with Nut Allergy

Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.
International Archives of Allergy and Immunology (Impact Factor: 2.43). 10/2010; 154(4):318-27. DOI: 10.1159/000321824
Source: PubMed

ABSTRACT Basophils contribute to anaphylaxis and allergies. We examined the utility of assessing basophil-associated surface antigens (CD11b/CD63/CD123/CD203c/CD294) in characterizing and monitoring subjects with nut allergy.
We used flow cytometry to analyze basophils at baseline (without any activation) and after ex vivo stimulation of whole blood by addition of nut or other allergens for 2, 10, and 30 min. We also evaluated whether basophil expression of CD11b/CD63/CD123/CD203c/CD294 was altered in subjects treated with anti-IgE monoclonal antibody (omalizumab) to reduce plasma levels of IgE.
We demonstrate that basophil CD203c levels are increased at baseline in subjects with nut allergy compared to healthy controls (13 subjects in each group, p < 0.0001). Furthermore, we confirm that significantly increased expression of CD203c occurs on subject basophils when stimulated with the allergen to which the subject is sensitive and can be detected rapidly (10 min of stimulation, n = 11, p < 0.0008). In 5 subjects with severe peanut allergy, basophil CD203c expression following stimulation with peanut allergen was significantly decreased (p < 0.05) after 4 and 8 weeks of omalizumab treatment but returned toward pretreatment levels after treatment cessation.
Subjects with nut allergy show an increase of basophil CD203c levels at baseline and following rapid ex vivo stimulation with nut allergen. Both can be reduced by omalizumab therapy. These results highlight the potential of using basophil CD203c levels for baseline diagnosis and therapeutic monitoring in subjects with nut allergy.

Download full-text


Available from: Eliver Eid Bou Ghosn, Aug 11, 2015
  • Source
    • "sting levels of CD203c are also reportedly high on baso - phils analyzed from food allergic subjects , suggesting an on - going activation of these cells in vivo . Interestingly , both omalizumab administration ( or anti - IgE therapy ) and sublin - gual / oral immunotherapy ( or desensitization ) protocols are reported to reduce this expression ( Gernez et al . , 2011 ; Keet et al . , in press ) . Decreased allergen - induced expression of CD63 has also been seen in the setting of many immunomodulatory - based trials . However , the specificity of these markers with respect to basophil degranulation has been questioned , and additional concerns relating to the ki - netics of expression , the addition"
    [Show abstract] [Hide abstract]
    ABSTRACT: In vitro basophil responses have long been used in mechanistic studies to help assess the human allergic diathesis, particularly during therapeutic intervention. Recent evidence points to the use of dendritic cells (DCs) in also being valuable in evaluating therapies aimed at lessening disease through immunomodulation. This review article therefore takes a look at some of the recent advances in old and new assays employing both basophils and DCs, with the added perception that the responses mediated by two cell types are insightful towards understanding immune cell mechanisms underlying allergic disease.
    Journal of immunological methods 01/2012; 383(1-2):21-9. DOI:10.1016/j.jim.2011.12.007 · 2.01 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The acceptance of flow cytometry (FCM) in clinical laboratory medicine is a major stepping stone towards development new cell analyses, improvement of accuracy, and finally a new range of diagnostic tests. Applications range from differential blood count determination to the identification of fluorescence-labeled subpopulations of disease-specific cell types in cell suspensions. Even new disease patterns can be identified by FCM. However, FCM is not only applicable for making a diagnosis but also for disease monitoring and routine check-ups. It is often used in oncology-related analyses, such as for leukemia and lymphoma patients. Here, not only cell numbers are relevant but also the degree of antigen expression which can be determined in a standardized way. Next to FCM also image cytometry has entered clinical applications although manual review by pathologists is still standard. In general, the multicolor approach and hence the ability for multiparametric analyses has led FCM to a central cornerstone in cell biology research. This review is intended to present an overview of cytometric applications which have entered clinical practice and led to deeper understanding in biological processes.
    Methods in cell biology 01/2011; 103:1-20. DOI:10.1016/B978-0-12-385493-3.00001-2 · 1.44 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: After approximately 130 years since their discovery as rare granulocytes that circulate in blood, basophils are just now gaining respect as significant contributors in the pathogenesis underlying allergic inflammation and disease. While long known for secreting preformed and newly synthesized mediators and for selectively infiltrating tissue during immunoglobulin E (IgE)-mediated inflammation, their role has largely been viewed as redundant to that of tissue mast cells in functioning as effector cells. This line of thought has persisted even though it has been known in humans for approximately 20 years that basophils additionally produce relatively large quantities of cytokines, e.g. interleukin-4 (IL-4)/IL-13, that are central for the manifestations of allergic disease. Studies using novel IL-4 reporter mice have significantly added to the in vivo importance of basophils as IL-4 producing cells, with recent findings indicating that these cells also function as antigen-presenting cells essential in initiating T-helper 2 responses. If confirmed and translated to humans, these provocative findings will give new meaning to the role basophils have in allergic disease, and in immunology overall.
    Immunological Reviews 07/2011; 242(1):144-60. DOI:10.1111/j.1600-065X.2011.01023.x · 12.91 Impact Factor
Show more